NYSE · CIK 0001631569
CHCT Community Healthcare Trust Inc
Insider trading from SEC Form 4. Last filing May 26, 2026. Close $13.61 on Oct 9, 2026, +14% from the 52-week low and -27% from the high.
Community Healthcare Trust Inc (CHCT) has 42 SEC Form 4 filings on file from 9 insiders, the latest filed on May 26, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
5 open-market trades have been scored at CHCT. The newest: Cathrine Cotman (director) bought $59k of stock on Nov 4, 2025, filed Nov 5, 2025, scored 25 (weak). The largest of the 5 shown: R. Lawrence Van Horn (director) bought $193k on May 28, 2025, scored 30 (weak). 2 insiders bought within 14 days of each other around May 13, 2025.
CHCT closed at $13.61 on Oct 9, 2026, 14% above its 52-week low and 27% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Community Healthcare Trust Inc, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | Cathrine Cotman director buy | $59k 4,000 shares | +12% | - | |
| 30Weak | R. Lawrence Van Horn director buy | $193k 11,815 shares | +15% | - | |
| 44Moderate | David H. Dupuy CEO and President buy | $162k 10,000 shares | +2% | - | |
| 33Weak | Cathrine Cotman director buy | $51k 3,000 shares | +14% | - | |
| 27Weak | Cathrine Cotman director sell | $51k 3,000 shares | -13% | - |
Transactions
Every row filed, 45 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | Claire M Gulmi director | AGrant or award Common Stock | +7,661 | $17.23 | $132k | 71,523 | May 26, 2026 |
| May 21, 2026 | R. Lawrence Van Horn director | AGrant or award Common Stock | +7,661 | $17.23 | $132k | 102,385 | May 26, 2026 |
| May 21, 2026 | Robert Z Hensley director | AGrant or award Common Stock | +6,036 | $17.23 | $104k | 95,702 | May 26, 2026 |
| May 21, 2026 | Cathrine Cotman director | AGrant or award Common Stock | +6,036 | $17.23 | $104k | 49,893 | May 26, 2026 |
| May 21, 2026 | Alan Gardner director | AGrant or award Common Stock | +7,661 | $17.23 | $132k | 104,521 | May 26, 2026 |
| May 7, 2026 | R. Lawrence Van Horn director | AGrant or award Common Stock | +6,222 | $0.00 | $0 | 94,724 | May 8, 2026 |
| May 7, 2026 | Alan Gardner director | AGrant or award Common Stock | +6,222 | $0.00 | $0 | 96,860 | May 8, 2026 |
| May 7, 2026 | Robert Z Hensley director | AGrant or award Common Stock | +6,222 | $0.00 | $0 | 89,666 | May 8, 2026 |
| May 7, 2026 | Cathrine Cotman director | AGrant or award Common Stock | +6,222 | $0.00 | $0 | 43,857 | May 8, 2026 |
| May 7, 2026 | Claire M Gulmi director | AGrant or award Common Stock | +6,222 | $0.00 | $0 | 63,862 | May 8, 2026 |
| Jan 15, 2026 | David H. Dupuy CEO and President | AGrant or award Common Stock | +29,941 | $16.70 | $500k | 534,245 | Jan 20, 2026 |
| Jan 15, 2026 | William G. Monroe IV Executive Vice President & CFO | AGrant or award Common Stock | +29,605 | $16.70 | $494k | 219,806 | Jan 20, 2026 |
| Jan 15, 2026 | Leigh Ann Stach Executive Vice President & CAO | AGrant or award Common Stock | +17,889 | $16.70 | $299k | 463,617 | Jan 20, 2026 |
| Jan 15, 2026 | Leigh Ann Stach Executive Vice President & CAO | FTax withholding Common Stock | -4,643 | $16.70 | $78k | 458,974 | Jan 20, 2026 |
| Nov 4, 2025 | Cathrine Cotman director | POpen-market purchase Common Stock | +4,000 | $14.66 | $59k | 37,635 | Nov 5, 2025 |
| Aug 7, 2025 | Leigh Ann Stach Executive Vice President & CAO | AGrant or award Common Stock | +17,529 | $15.85 | $278k | 445,728 | Aug 8, 2025 |
| Aug 7, 2025 | David H. Dupuy CEO and President | AGrant or award Common Stock | +29,338 | $15.85 | $465k | 504,304 | Aug 8, 2025 |
| Aug 7, 2025 | William G. Monroe IV Executive Vice President & CFO | AGrant or award Common Stock | +29,009 | $15.85 | $460k | 190,201 | Aug 8, 2025 |
| Jul 24, 2025 | David H. Dupuy CEO and President | AGrant or award Common Stock | +17,518 | $0.00 | $0 | 474,966 | Jul 28, 2025 |
| Jul 24, 2025 | Leigh Ann Stach Executive Vice President & CAO | AGrant or award Common Stock | +9,662 | $0.00 | $0 | 428,199 | Jul 28, 2025 |
| Jul 24, 2025 | William G. Monroe IV Executive Vice President & CFO | AGrant or award Common Stock | +11,433 | $0.00 | $0 | 161,192 | Jul 28, 2025 |
| Jun 30, 2025 | Leigh Ann Stach Executive Vice President & CAO | FTax withholding Common Stock | -604 | $16.77 | $10k | 418,537 | Jul 2, 2025 |
| Jun 30, 2025 | William G. Monroe IV Executive Vice President & CFO | FTax withholding Common Stock | -650 | $16.77 | $11k | 149,759 | Jul 2, 2025 |
| Jun 30, 2025 | David H. Dupuy CEO and President | FTax withholding Common Stock | -1,052 | $16.77 | $18k | 457,448 | Jul 2, 2025 |
| Jun 2, 2025 | William G. Monroe IV Executive Vice President & CFO | AGrant or award Common Stock | +7,000 | $0.00 | $0 | 150,409 | Jun 3, 2025 |
| May 28, 2025 | R. Lawrence Van Horn director | POpen-market purchase Common Stock | +11,815 | $16.37 | $193k | 88,502 | May 30, 2025 |
| May 15, 2025 | Claire M Gulmi director | AGrant or award Common Stock | +7,933 | $16.64 | $132k | 56,950 | May 16, 2025 |
| May 15, 2025 | Alan Gardner director | AGrant or award Common Stock | +15,865 | $16.64 | $264k | 90,638 | May 16, 2025 |
| May 15, 2025 | R. Lawrence Van Horn director | AGrant or award Common Stock | +7,933 | $16.64 | $132k | 76,687 | May 16, 2025 |
| May 15, 2025 | Cathrine Cotman director | AGrant or award Common Stock | +6,250 | $16.64 | $104k | 33,635 | May 16, 2025 |
| May 15, 2025 | Robert Z Hensley director | AGrant or award Common Stock | +6,250 | $16.64 | $104k | 83,444 | May 16, 2025 |
| May 13, 2025 | David H. Dupuy CEO and President | POpen-market purchase Common Stock | +10,000 | $16.23 | $162k | 458,500 | May 14, 2025 |
| May 1, 2025 | Claire M Gulmi director | AGrant or award Common Stock | +6,524 | $0.00 | $0 | 49,017 | May 2, 2025 |
| Apr 30, 2025 | Cathrine Cotman director | POpen-market purchase Common Stock | +3,000 | $17.10 | $51k | 23,861 | May 2, 2025 |
| May 1, 2025 | Alan Gardner director | AGrant or award Common Stock | +6,524 | $0.00 | $0 | 74,773 | May 2, 2025 |
| May 1, 2025 | Robert Z Hensley director | AGrant or award Common Stock | +6,524 | $0.00 | $0 | 77,194 | May 2, 2025 |
| May 1, 2025 | R. Lawrence Van Horn director | AGrant or award Common Stock | +6,524 | $0.00 | $0 | 68,754 | May 2, 2025 |
| Apr 30, 2025 | Cathrine Cotman director | SOpen-market sale Common Stock | -3,000 | $17.09 | $51k | 20,861 | May 2, 2025 |
| May 1, 2025 | Cathrine Cotman director | AGrant or award Common Stock | +6,524 | $0.00 | $0 | 27,385 | May 2, 2025 |
| Jan 15, 2025 | William G. Monroe IV Executive Vice President & CFO | AGrant or award Common Stock | +25,981 | $19.03 | $494k | 143,409 | Jan 17, 2025 |
| Jan 15, 2025 | Timothy L. Meyer EVP - Asset Management | AGrant or award Common Stock | +18,380 | $19.03 | $350k | 202,825 | Jan 17, 2025 |
| Jan 15, 2025 | Leigh Ann Stach Executive Vice President & CAO | AGrant or award Common Stock | +15,699 | $19.03 | $299k | 419,141 | Jan 17, 2025 |
| Jan 15, 2025 | David H. Dupuy CEO and President | AGrant or award Common Stock | +26,275 | $19.03 | $500k | 448,500 | Jan 17, 2025 |
| Jan 14, 2025 | Timothy L. Meyer EVP - Asset Management | FTax withholding Common Stock | -84 | $18.93 | $1,590 | 184,445 | Jan 15, 2025 |
| Jan 13, 2025 | Leigh Ann Stach Executive Vice President & CAO | FTax withholding Common Stock | -4,137 | $18.90 | $78k | 403,442 | Jan 14, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Cathrine Cotmandirector
- David H. DupuyCEO and President
- Claire M Gulmidirector
- Alan Gardnerdirector
- Robert Z Hensleydirector
- Timothy L. MeyerEVP - Asset Management
- William G. Monroe IVExecutive Vice President & CFO
- Leigh Ann StachExecutive Vice President & CAO
- R. Lawrence Van Horndirector
Questions about CHCT
Answered from the filings on this page, as of the latest one.
Are insiders buying CHCT?
No. In the last 90 days no insider at Community Healthcare Trust Inc bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade CHCT on the open market?
Cathrine Cotman (director) bought $59k of CHCT on Nov 4, 2025 and filed the Form 4 on Nov 5, 2025. InsiderTell scored 25 (weak).
How many insiders file Form 4 at Community Healthcare Trust Inc?
9 people have filed a Form 4 at Community Healthcare Trust Inc, among them Cathrine Cotman (director), David H. Dupuy (CEO and President), Claire M Gulmi (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.